 | Kulik MC, Lee YO, Butsic V, Cermak TL, Cooper ZD, Corva D, Marcotte TD, Uskup DK, McKnight TR, Balla A. (2024). California Cannabis Research Briefing, April 2023: Meeting Summary. Cannabis and Cannabinoid Research, Epub May 7. PMID: 38717853 |
 | Avalos B, Kulbe JR, Ford MK, Laird AE, Walter K, Mante M, Florio JB, Boustani A, Chaillon A, Schlachetzki JCM, Sundermann EE, Volsky DJ, Rissman RA, Ellis RJ, Letendre SL, Iudicello J, Fields JA. (2024). Cannabis use and cannabidiol modulate HIV-Induced alterations in TREM2 expression: Implications for age-related neuropathogenesis. Viruses, 16(10), 1509. PMID: 39459844 PMCID: 11512329 |
 | Wilson JN, Mendez DA, Dhoro F, Shevchenko N, Mescal M, Lund K, Fitzgerald R, DiPatrizio NV, Ortiz RM. (2024). Pseudocannabinoid H4CBD improves glucose response during advanced metabolic syndrome in OLETF rats independent of increase in insulin signaling proteins. American Journal of Physiol Intgr Comp Physiol, 326(2), R100-R109. PMCID: 37899754 |
 | Watson CW-M, Sundermann E, Helm J, Paolillo EW, Hong S, Ellis RJ, Letendre S, Marcotte TD, Heaton RK, Morgan EE, Grant I. (2023). A longitudinal study of cannabis use and risk for cognitive and functional decline among older adults with HIV. AIDS and Behavior, 27(10), 3401-3413. PMID: 37155086 PMCID: 10766343 |
 | Rogers JM, Grant I, Marcondes MCG, Morgan EE, Cherner M, Ellis RJ, Letendre SL, Heaton RK, Iudicello JE. (2023). Cannabis use may attenuate neurocognitive performance deficits resulting from methamphetamine use disorder. Journal of the International Neuropsychological Society, 30(1), 84-93. PMID: 37553288 PMCID: 10841263 |
 | Fitzgerald RL, Umlauf A, Hubbard JA, Hoffman MA, Sobolesky PM, Ellis SE, Grelotti DJ, Suhandynata RT, Huestis MA, Grant I, Marcotte TD. (2023). Driving under the influence of cannabis: Impact of combining toxicology testing with field sobriety tests. Clinical Chemistry, 59(7), 724-733. PMID: 37228223 PMCID: 10320013 |
 | Marcotte TD, Umlauf A, Grelotti DJ, Sones EG, Mastropietro KF, Suhandynata RT, Huestis MA, Grant I, Fitzgerald RL. (2023). Evaluation of field sobriety tests for identifying drivers under the influence of cannabis: A randomized clinical trial. JAMA Psychiatry, 80(9), 914-923. PMID: 37531115 PMCID: 10398547 |
 | Rogers JM, Iudicello JE, Marcondes MCG, Morgan EE, Cherner M, Ellis RJ, Letendre SL, Heaton RK, Grant I. (2023). The combined effects of cannabis, methamphetamine, and HIV on neurocognition. Viruses, 15(3), 674. PMID: 36992383 PMCID: 10058939 |
 | Smith RC, Sershen H, Janowsky DS, Lajtha A, Grieco M, Gangoiti JA, Gertsman I, Johnson WS, Marcotte TD, Davis JM. (2022). Changes in expression of DNA-methyltransferase and cannabinoid receptor MRNAs in blood lymphocytes after acute cannabis smoking. Frontiers in Psychiatry, 13, 887700. PMID: 35859599 PMCID: PMC9290435 |
 | Marcotte TD, Umlauf A, Grelotti DJ, Sones EG, Sobolesky PM, Smith BE, Hoffman MA, Hubbard JA, Severson J, Huestis MA, Grant I, Fitzgerald RL. (2022). Driving performance and cannabis users' perception of safety. JAMA Psychiatry, 79(3), 201-209. PMID: 35080588 PMCID: PMC8792796 |
 | Basova LV, Lukkes SE, Milner R, Ellis RJ, Cherner M, Iudicello J, Marcondes MCG. (2022). Polygenic networks in peripheral leukocytes indicate patterns associated with HIV infection and context-dependent effects of cannabis use. Brain, Behavior, & Immunity - Health, 20, 100414. PMID: 35128491 PMCID: PMC8808072 |
 | Mosaed S, Smith AK, Liu JHK, Minckler DS, Fitzgerald RL, Grelotti D, Sones E, Weinreb RN, Marcotte TD. (2022). The relationship between plasma tetrahydrocannabinol levels and intraocular pressure in healthy adult subjects. Frontiers in Medicine, 8, 736792. PMID: 35111768 PMCID: PMC8801518 |
 | Ellis RJ, Peterson S, Cherner M, Morgan E, Schrier R, Tang B, Hoenigl M, Letendre S, Iudicello J. (2021). Beneficial effects of cannabis on blood brain barrier function in HIV. Clinical Infectious Diseases, 73(1), 124-129. PMID: 32296832 |
 | Hubbard JA, Hoffman MA, Ellis SE, Sobolesky PM, SMith BE, Suhandynata RT, Sones EG, Sanford SK, Umlauf A, Huestis MA, Grelotti DG, Grant I, Marcotte TD, Fitzgerald RL. (2021). Biomarkers of recent cannabis use in blood, oral fluid and breath. Journal of Analytical Toxicology, 45(8), 820-828. PMID: 34185831 |
 | Hoffman MA, Hubbard JA, Sobolesky PM, Smith BE, Suhandynata RT, Sanford S, Sones E, Ellis S, Umlauf A, Huestis MA, Grelotti DJ, Grant I, Marcotte TD, Fitzgerald RL. (2021). Blood and oral fluid cannabinoid profiles of frequent and occasional cannabis smokers. Journal of Analytical Toxicology, 45(8), 851-862. PMID: 34173005 |
 | Smith LC, Tieu L, Suhandynata RT, Boomhower B, Hoffman M, Sepulveda Y, Carrett LLG, Momper JD, Fitzgerald RL, Hanham K, Dowling J, Kallupi M, George O. (2021). Cannabidiol reduces withdrawal symptoms in nicotine-dependent rats. Psychopharmacology, 238(8), 2201-2211. PMID: 33909102 PMCID: PMC8295227 |
 | Watson CW, Campbell LM, Sun-Suslow N, Hong S, Umlauf A, Ellis RJ, Iudicello JE, Letendre S, Marcotte TD, Heaton RK, Morgan EE, Grant I. (2021). Daily cannabis use is associated with lower CNS inflammation in people with HIV. Journal of the International Neuropsychological Society, 27(6), 661-672. PMID: 34261550 PMCID: PMC8288448 |
 | Roberts BZ, Minassian A, Halberstadt AL, He YV, Chatha M, Geyer MA, Grant I, Young JW. (2021). HIV transgenic rats demonstrate impaired sensorimotor gating, but are insensitive to cannabinoid (delta-9-tetrahydrocannabinol)-induced deficits. The International Journal of Neuropsychopharmacology, 24(11), 894-906. PMID: 34338765 PMCID: PMC8598295 |
 | Watson CW, Paolillo EW, Morgan EE, Umlauf A, Sundermann EE, Ellis RJ, Letendre S, Marcotte TD, Heaton RK, Grant I. (2020). Cannabis exposure is associated with a lower likelihood of neurocognitive impairment in people living with HIV. Journal of Acquired Immune Deficiency Syndromes, 83(1), 56-64. PMID: 31809361 PMCID: PMC6901104 |
 | Saloner R, Fields JA, Marcondes MCG, Iudicello JE, von Kanel S, Cherner M, Letendre SL, Kaul M, Grant I, and the TMARC Group. (2020). Methamphetamine and cannabis: A tale of two drugs and their effects on HIV, brain, and behavior. Journal of Neuroimmune Pharmacology, 15(4), 743-764. PMID: 32929575 PMCID: PMC7719083 |
 | Ellis RJ, Peterson SN, Li Y, Schrier R, Iudicello J, Letendre S, Morgan E, Tang B, Grant I, Cherner M. (2020). Recent cannabis use in HIV is associated with reduced inflammatory markers in CSF and blood. Neurology, Neuroimmunology & Neuroinflammation, 7(5), e809. PMID: 32554630 PMCID: PMC7309527 |
 | Mosaed S, Liu JHK, Minckler DS, Fitzgerald RL, Grelotti D, Sones E, Shiels CR, Weinreb RN, Marcotte TD. (2020). The effect of inhaled cannabis on intraocular pressure in healthy adult subjects. TouchReviews in Ophthalmology, 15(1), 33-37. |
 | Hubbard JA, Smith BE, Sobolesky PM, Kim S, Hoffman MA, Stone J, Huestis MA, Grelotti DJ, Grant I, Marcotte T, Fitzgerald RL. (2020). Validation of a liquid chromatography tandem mass spectrometry (LC-MS/MS) method to detect cannabinoids in whole blood and breath. Clinical Chemistry And Laboratory Medicine, 58(5), 673-681. PMID: 31527291 |
 | Tyree GA, Sarkar R Bellows BK, Ellis RJ, Atkinson JH, Marcotte TD, Wallace MS, Grant I, Shi Y, Murphy JD, Grelotti DJ. (2019). A cost-effectiveness model for adjunctive smoked cannabis in the treatment of chronic neuropathic pain. Cannabis And Cannabinoid Research, 4(1), 62-72. PMID: 30944870 PMCID: PMC6446169 |
 | Andreae MH, Carter GM, Shaparin N, Suslov K, Ellis RJ, Ware MA, Abrams DI, Prasad H, Wilsey B, Indyk D, Johnson M, Sacks HS. (2015). Inhaled cannabis for chronic neuropathic pain: An individual patient data meta-analysis. The Journal of Pain, 16(12), 1221-1232. PMID: 26362106 PMCID: PMC4666747 |
 | Grant I. (2015). Medical Use of Cannabinoids--Reply. Comment on Cannabinoids for Medical Use: A Systematic Review and Meta-analysis. JAMA: The Journal of the American Medical Association, 314(16), 1750-1751. PMID: 26505602 |
| Cattie J, Grant I. (2014). Cannabis. In DN Allen and SP Woods (Eds.), Neuropsychological Aspects of Substance Use Disorders. , (pp. 134-156). New York: Oxford University Press. |
 | Ellis RJ, Toperoff W, Vaida F, van den Brande G, Gonzales J, Gouaux B, Bentley H, Atkinson JH. (2009). Smoked medicinal cannabis for neuropathic pain in HIV: a randomized, crossover clinical trial. Neuropsychopharmacology : Official Publication of The American College of Neuropsychopharmacology, 34(3), 672-80. PMID: 18688212 PMCID: PMC3066045 |
 | Wilsey B, Marcotte T, Tsodikov A, Millman J, Bentley H, Gouaux B, Fishman S. (2008). A randomized, placebo-controlled, crossover trial of cannabis cigarettes in neuropathic pain. The Journal of Pain : Official Journal of The American Pain Society, 9(6), 506-521. PMID: 18403272 |
 | Abrams DI, Jay CA, Shade SB, Vizoso H, Reda H, Press S, Kelly ME, Rowbotham MC, Petersen KL. (2007). Cannabis in painful HIV-associated sensory neuropathy: a randomized placebo-controlled trial. Neurology, 68(7), 515-521. PMID: 17296917 |
| Gonzalez R, Martin EM, Grant I. (2007). Marijuana. A Kalechsten & WG van Gorp (Eds.), Neuropsychology and Substance Use. State-of-the-Art and Future Directions. , (pp. 139-170). Taylor & Francis Group. |
 | Grant I, Rochford J, Fleming T, Stunkard A. (1973). A neuropsychological assessment of the effects of moderate marijuana use. Journal of Nervous and Mental Disease, 156, 278-280. PMID: 4708887 | |